TAT complexes and prothrombin fragment 1 + 2 in oral contraceptive users.
Saleh
A A
AA
Department of Obstetrics and Gynecology, Wayne State University, Hutzel Hospital, Detroit, MI.
Brockbank
N
N
Dorey
L G
LG
Ozawa
T
T
Dombrowski
M P
MP
Bottoms
S F
SF
Cotton
D B
DB
Mammen
E F
EF
D000328:Adult; D000990:Antithrombin III / Q000032:analysis*; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D010447:Peptide Hydrolases / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D012907:Smoking
D015415:Biomarkers; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D010446:Peptide Fragments; C046193:antithrombin III-protease complex; C045879:prothrombin fragment 1.2; D004997:Ethinyl Estradiol; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases